Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ASPI
stocks logo

ASPI

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
2.05M
+71.37%
-0.100
-16.67%
5.09M
+362.05%
-0.120
-7.69%
9.94M
+729.68%
-0.110
-8.33%
Estimates Revision
The market is revising Downward the revenue expectations for ASP Isotopes Inc. (ASPI) for FY2025, with the revenue forecasts being adjusted by -34.4% over the past three months. During the same period, the stock price has changed by -18.71%.
Revenue Estimates for FY2025
Revise Downward
down Image
-34.4%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+6.72%
In Past 3 Month
Stock Price
Go Down
down Image
-18.71%
In Past 3 Month
Wall Street analysts forecast ASPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPI is 13.00 USD with a low forecast of 11.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast ASPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPI is 13.00 USD with a low forecast of 11.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 6.670
sliders
Low
11.00
Averages
13.00
High
15.00
Current: 6.670
sliders
Low
11.00
Averages
13.00
High
15.00
Cantor Fitzgerald
Derek Soderberg
initiated
$13
2025-12-04
New
Reason
Cantor Fitzgerald
Derek Soderberg
Price Target
$13
2025-12-04
New
initiated
Reason
Cantor Fitzgerald analyst Derek Soderberg initiated coverage of ASP Isotopes with an Overweight rating and $13 price target.
Lucid Capital
Alex Fuhrman
Buy
initiated
$15
2025-10-27
Reason
Lucid Capital
Alex Fuhrman
Price Target
$15
2025-10-27
initiated
Buy
Reason
Lucid Capital analyst Alex Fuhrman initiated coverage of ASP Isotopes with a Buy rating and $15 price target. The company is "entering a phase of rapid growth" as it transitions to commercial production of isotopes with the potential to transform a wide range of high-tech industries, the analyst tells investors in a research note. The firm sees ASP as well positioned to help reduce the West's dependence on Russian isotope supplies critical to medicine and nuclear power.
Canaccord
Buy
upgrade
$11
2025-05-21
Reason
Canaccord
Price Target
$11
2025-05-21
upgrade
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for ASP Isotopes Inc (ASPI.O) is -18.03, compared to its 5-year average forward P/E of -18.18. For a more detailed relative valuation and DCF analysis to assess ASP Isotopes Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-18.18
Current PE
-18.03
Overvalued PE
-1.02
Undervalued PE
-35.34

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.10
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
35.47
Undervalued EV/EBITDA
-37.67

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
14.31
Current PS
0.00
Overvalued PS
25.31
Undervalued PS
3.32
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

ASPI News & Events

Events Timeline

(ET)
2025-12-04
16:20:00
Major Averages Close Little Changed as Jobless Claims Fall to 191,000
select
2025-12-04
12:00:00
Major U.S. Indices Little Changed as Investors Anticipate Fed Rate Cut
select
2025-12-03 (ET)
2025-12-03
06:10:00
Aspire Biopharma Files to Sell 41.5M Shares of Common Stock
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
12-04Benzinga
Donaldson Reports Positive Results and Teams Up with Science Applications International, Descartes Systems, Dollar General, and Other Major Stocks Rising on Thursday

  • U.S. Stock Market Performance: U.S. stocks declined slightly, with the Dow Jones falling about 0.1% on Thursday, while several companies reported strong earnings and raised their guidance.

  • Donaldson Company Earnings: Donaldson Company, Inc. saw a 4.7% increase in its stock price after reporting a 3.9% year-over-year sales growth and raising its fiscal 2026 adjusted EPS guidance.

  • Notable Stock Gains: UiPath Inc. and Science Applications International Corporation experienced significant stock price increases of 16.5% and 15.8%, respectively, following better-than-expected financial results and raised guidance.

  • Other Companies with Gains: Several other companies, including ASP Isotopes Inc. and BioAge Labs, also saw notable stock price increases due to positive financial news and analyst ratings.

[object Object]
Preview
6.0
12-04SeekingAlpha
ASP Isotopes Rated Overweight by Cantor Due to Upcoming Spinoff Value Generation

  • Stock Performance: ASP Isotopes (ASPI) saw a 17.5% increase in trading after Cantor Fitzgerald initiated coverage with an Overweight rating and a $13 price target, citing potential shareholder value from an upcoming spinoff of its Quantum Leap Energy subsidiary.

  • HALEU Demand: The spinoff will focus on quantum enrichment technology for high-assay low-enriched uranium (HALEU), with expectations that HALEU demand could reach tens of billions by the early 2030s, primarily due to the growth of small modular reactors.

  • Strategic Partnerships: ASP Isotopes has a supply framework agreement with TerraPower, which includes funding for the construction of a ton-scale HALEU plant dedicated to supplying TerraPower, reinforcing its position in the HALEU market.

  • Helium Asset Acquisition: The company is also in the process of acquiring a distressed asset from Renergen, which could provide access to the world's largest helium deposit, potentially supplying around 12% of global helium from just 4% of the reserve.

[object Object]
Preview
4.0
12-04Benzinga
AutoZone Analyst Starts Coverage Optimistically; Check Out Thursday's Top 5 Initiations

  • Analyst Coverage Initiations: Several top Wall Street analysts have initiated coverage on various companies, providing new ratings and price targets.

  • Solid Biosciences Inc: Needham analyst Gil Blum rated Solid Biosciences with a Buy and set a price target of $16, while shares closed at $5.19.

  • AutoZone, Inc: Baird analyst Justin Kleber rated AutoZone as Outperform with a price target of $4,500, with shares closing at $3,822.92.

  • Other Companies: Analysts also initiated coverage on ASP Isotopes, Paymentus Holdings, and monday.com, with respective ratings and price targets indicating potential growth.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is ASP Isotopes Inc (ASPI) stock price today?

The current price of ASPI is 6.67 USD — it has increased 16.4 % in the last trading day.

arrow icon

What is ASP Isotopes Inc (ASPI)'s business?

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

arrow icon

What is the price predicton of ASPI Stock?

Wall Street analysts forecast ASPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPI is 13.00 USD with a low forecast of 11.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is ASP Isotopes Inc (ASPI)'s revenue for the last quarter?

ASP Isotopes Inc revenue for the last quarter amounts to 4.89M USD, increased 349.53 % YoY.

arrow icon

What is ASP Isotopes Inc (ASPI)'s earnings per share (EPS) for the last quarter?

ASP Isotopes Inc. EPS for the last quarter amounts to -0.15 USD, increased 25.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for ASP Isotopes Inc (ASPI)'s fundamentals?

The market is revising Downward the revenue expectations for ASP Isotopes Inc. (ASPI) for FY2025, with the revenue forecasts being adjusted by -34.4% over the past three months. During the same period, the stock price has changed by -18.71%.
arrow icon

How many employees does ASP Isotopes Inc (ASPI). have?

ASP Isotopes Inc (ASPI) has 136 emplpoyees as of December 05 2025.

arrow icon

What is ASP Isotopes Inc (ASPI) market cap?

Today ASPI has the market capitalization of 739.30M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free